genprowebdirectory
Facebook Linkedin RSS Twitter Youtube
  • GEN Edge
    • Featured News
    • Multimedia
  • News
    • Insights
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • Magazine
    • Browse Issues
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • GEN Live
    • Learning Labs
    • Podcasts
  • Resources
    • A-Lists
    • eBooks/Perspectives
    • Tutorials
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
Search
Facebook Linkedin RSS Twitter Youtube
Sign in
Welcome! Log into your account
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
A password will be e-mailed to you.
Genetic Engineering & Biotechnology News GEN – Genetic Engineering and Biotechnology News
Genetic Engineering & Biotechnology News Genetic Engineering & Biotechnology News
  • GEN Edge
    • Featured News
    • Multimedia
  • News
    • Insights
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • Magazine
    • Browse Issues
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • GEN Live
    • Learning Labs
    • Podcasts
  • Resources
    • A-Lists
    • eBooks/Perspectives
    • Tutorials
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
Home 2024

Roche Pharma

Absci Eyes Busy 2025 as Lead AI-Designed Candidate Heads for Clinic
Artificial Intelligence

Absci Eyes Busy 2025 as Lead AI-Designed Candidate Heads for Clinic

StockWatch: Regeneron Shares Dip as DOJ Alleges Fraudulent Price Reporting
Drug Discovery

StockWatch: Regeneron Shares Dip as DOJ Alleges Fraudulent Price Reporting

Lonza to Buy Genentech’s Vacaville, CA Biologics Manufacturing Site for $1.2B
Bioprocessing

Lonza to Buy Genentech’s Vacaville, CA Biologics Manufacturing Site for $1.2B

With $86M Oversubscribed Public Offering, Absci Eyes 2025 IND for Lead Candidate
Artificial Intelligence

With $86M Oversubscribed Public Offering, Absci Eyes 2025 IND for Lead Candidate

GenEdit Tackles “Delivery, Delivery, Delivery” with Up-to-$644M Genentech Collaboration
Drug Discovery

GenEdit Tackles “Delivery, Delivery, Delivery” with Up-to-$644M Genentech Collaboration

StockWatch: Analysts Weigh Obesity Drug Market Pegged at $100B by 2030
Drug Discovery

StockWatch: Analysts Weigh Obesity Drug Market Pegged at $100B by 2030

Roche to Acquire Carmot Therapeutics for Up to $3.1B
Drug Discovery

Roche to Acquire Carmot Therapeutics for Up to $3.1B

Roche, Dicerna Launch Up-to-$1.67B Hepatitis B Collaboration
GEN Edge

Roche, Dicerna Launch Up-to-$1.67B Hepatitis B Collaboration

Got Milk? Roche to Apply PureTech Exosomes Platform in $1B+ Collaboration
Industry News

Got Milk? Roche to Apply PureTech Exosomes Platform in $1B+ Collaboration

Application Note: Mimicking Natural Antibody Recycling for In Vitro Pharmacokinetics Studies
Drug Discovery

Application Note: Mimicking Natural Antibody Recycling for In Vitro Pharmacokinetics Studies

12Page 1 of 2

Read the Digital Edition

June 2024 cover

Explore

  • About GEN
  • Contact GEN
  • GEN Staff
  • Editorial Guidelines
  • Reprints and Permissions
  • Scientific Advisory Board

Advertise

  • Media Kit and Planning Calendar
  • Advertising Terms and Conditions

Resources

  • Get the GEN Magazine
  • Get the GEN Email Newsletter
  • Inside Precision Medicine
  • Privacy Policy
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Scroll Up